Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax.
Stefano CordellaDavide GiustiEleonora De BellisMichelina DargenioFederica Creti'Davide LazzarottoChiara CattaneoNicola Stefano FracchiollaMatteo PicciniFabio ForghieriLivio PaganoAnna CandoniPublished in: Hematological oncology (2024)